Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$17,500.00
Cognitive Rehabilitation 'Mega Team' and its Effects on Emotional and Behavioural Regulation in Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, and Congenital Heart Defect: a Cost-effectiveness Analysis
EF 2021-22
Résumé
Children with disorders that impact their neurodevelopment find it more difficult to regulate their emotions and behaviour. This dysregulation arises from executive function impairments that characterize different disorders, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and a wide range of medical conditions that disrupt early brain development such as Congenital Heart Defects (CHD). Current treatment plans to improve executive functioning rely heavily on medication which have well-known limitations, undesired side-effects, and are not universally accepted. There is a need for a safer, cost-effective, and evidence-informed alternative to support cognitive rehabilitation in children. Mega Team is a novel, game-based cognitive intervention that trains multiple executive functions. It represents a promising, non-pharmacologic intervention that would be readily-available, safer for use, and more cost-effective. Its effectiveness is currently being evaluated in a prospective randomized controlled trial in children aged 6-12. In this study, I will conduct an economic evaluation that examines the effectiveness of the Mega Team treatment relative to its costs when compared to standard treatment plans. Other measures will include health-related quality of life as defined by the patients, parents, and caregivers to incorporate the unique experiences and views.This cost-effectiveness analysis would inform reimbursement decision-making as well as inform treatment decisions for a larger group of children with executive function impairments. This evidence could help clinical care teams and parents make more efficient decisions on safer, more readily available non-pharmacologic treatment options that require minimal supervision.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
467243
Name
Shoukry Roaa
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Cognitive Rehabilitation 'Mega Team' and its Effects on Emotional and Behavioural Regulation in Attention Deficit Hyperactivity Disorder, Autism Spectrum Disorder, and Congenital Heart Defect: a Cost-effectiveness Analysis
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Autism; Children Mental Health; Cost Analysis; Cost-Effectiveness Analysis; Economic Evaluation; Executive Dysfunction; Health Services Research; Health Technology Assessment; Neurodevelopmental Disorders; Non-Pharmacologic Interventions
Abstract
Children with disorders that impact their neurodevelopment find it more difficult to regulate their emotions and behaviour. This dysregulation arises from executive function impairments that characterize different disorders, including Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), and a wide range of medical conditions that disrupt early brain development such as Congenital Heart Defects (CHD). Current treatment plans to improve executive functioning rely heavily on medication which have well-known limitations, undesired side-effects, and are not universally accepted. There is a need for a safer, cost-effective, and evidence-informed alternative to support cognitive rehabilitation in children. Mega Team is a novel, game-based cognitive intervention that trains multiple executive functions. It represents a promising, non-pharmacologic intervention that would be readily-available, safer for use, and more cost-effective. Its effectiveness is currently being evaluated in a prospective randomized controlled trial in children aged 6-12. In this study, I will conduct an economic evaluation that examines the effectiveness of the Mega Team treatment relative to its costs when compared to standard treatment plans. Other measures will include health-related quality of life as defined by the patients, parents, and caregivers to incorporate the unique experiences and views.This cost-effectiveness analysis would inform reimbursement decision-making as well as inform treatment decisions for a larger group of children with executive function impairments. This evidence could help clinical care teams and parents make more efficient decisions on safer, more readily available non-pharmacologic treatment options that require minimal supervision.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Shoukry, Roaa
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~